Patrick Treanor's most recent trade in KalVista Pharmaceuticals Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KalVista Pharma Inc | Patrick Treanor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| KalVista Pharma Inc | Patrick Treanor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| KalVista Pharma Inc | Patrick Treanor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 17,000 | 17,000 | - | - | Stock Option (right to buy) |